Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
The FDA’s more stringent review of medical devices means that some technologies may hit European markets years before they’re available to U.S. patients, and that has some doctors concerned.
Recalled medical devices, such as Medtronic’s Sprint Fidelis defibrillator leads, may pose a high and perhaps under-recognized risk in pediatric populations.
Federal authorities accuse the founder and former CEO of Energex Systems of stealing investors’ funds to cover personal gambling debts, vacations and political donations.